205 related articles for article (PubMed ID: 31781391)
1. Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital.
Mugendi AG; Kubo MN; Nyamu DG; Mwaniki LM; Wahome SK; Haberer JE
Neurol Res Int; 2019; 2019():5173289. PubMed ID: 31781391
[TBL] [Abstract][Full Text] [Related]
2. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
Nyundo AA
PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive Disorders in HIV-positive Patients.
Padole PS; Padhiyar RN; Yadav DS; Chavan SA
J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
[TBL] [Abstract][Full Text] [Related]
4. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
[TBL] [Abstract][Full Text] [Related]
5. Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment.
Aita SL; Kaewpoowat Q; Yasri S; Rerkasem A; Rerkasem K; Choovuthayakorn J; Ausayakhun S; Robertson K; Roth RM; Robbins NM
J Neurovirol; 2021 Aug; 27(4):568-578. PubMed ID: 34185242
[TBL] [Abstract][Full Text] [Related]
6. [Neurocognitive impairment and characteristics of neurocognitive performance among people with HIV on antiretroviral treatment].
Xia JJ; Wang SL; Hu YF; Shen WW; Lin HJ; Shi RZ; Ma ZH; Li ZH; Li SZ; Ding YY; Chen XX; He N
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1651-1657. PubMed ID: 36456499
[No Abstract] [Full Text] [Related]
7. HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya.
Mohamed AA; Oduor C; Kinyanjui D
BMC Neurol; 2020 Jul; 20(1):280. PubMed ID: 32664858
[TBL] [Abstract][Full Text] [Related]
8. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
9. Determining the Neurocognitive Status and the Functional Ability of Patients to Screen for HIV-Associated Neurocognitive Disorder (HAND).
Agarwal R; Aujla RS; Gupta A; Kumar M
Dement Neurocogn Disord; 2020 Mar; 19(1):19-27. PubMed ID: 32174047
[TBL] [Abstract][Full Text] [Related]
10. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV-2 population.
Almeida F; Macedo A; Trigo D; Abreu M; Guimarães M; Luís N; Pinho R; Tavares R
HIV Med; 2021 Mar; 22(3):212-217. PubMed ID: 33012065
[TBL] [Abstract][Full Text] [Related]
12. HIV-Associated Dementia: Associated Factors and Characteristics of Cognitive Domain Abnormalities in Elderly People Living with HIV Treated with Highly Active Antiretroviral Therapy.
Boonyagars L; Kiatsoongsong N; Winitprichagul S
Am J Trop Med Hyg; 2022 Dec; 107(6):1250-1257. PubMed ID: 36315995
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors of Asymptomatic Neurocognitive Impairment in People Living with HIV in an Indian Cohort.
Gupta S; Venugopal N
J Neurosci Rural Pract; 2020 Apr; 11(2):230-236. PubMed ID: 32367976
[No Abstract] [Full Text] [Related]
14. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
15. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia.
Tsegaw M; Andargie G; Alem G; Tareke M
J Psychiatr Res; 2017 Feb; 85():37-41. PubMed ID: 27821271
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia.
Ayele G; Tessema B; Amsalu A; Ferede G; Yismaw G
BMC Immunol; 2018 Dec; 19(1):37. PubMed ID: 30558580
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.
Njamnshi AK; Bissek AC; Ongolo-Zogo P; Tabah EN; Lekoubou AZ; Yepnjio FN; Fonsah JY; Kuate CT; Angwafor SA; Dema F; Njamnshi DM; Kouanfack C; Djientcheu Vde P; Muna WF; Kanmogne GD
J Neurol Sci; 2009 Oct; 285(1-2):149-53. PubMed ID: 19631349
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
[TBL] [Abstract][Full Text] [Related]
19. The association between asymptomatic and mild neurocognitive impairment and adherence to antiretroviral therapy among people living with human immunodeficiency virus.
Awori V; Mativo P; Yonga G; Shah R
South Afr J HIV Med; 2018; 19(1):674. PubMed ID: 29707383
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Predictors of Neurocognitive Impairment in Ethiopian Population Living with HIV.
Salahuddin M; Manzar MD; Hassen HY; Unissa A; Abdul Hameed U; Spence DW; Pandi-Perumal SR
HIV AIDS (Auckl); 2020; 12():559-572. PubMed ID: 33116918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
